584 related articles for article (PubMed ID: 20467795)
1. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
Micalizzi DS; Farabaugh SM; Ford HL
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
[TBL] [Abstract][Full Text] [Related]
3. ErbB/EGF signaling and EMT in mammary development and breast cancer.
Hardy KM; Booth BW; Hendrix MJ; Salomon DS; Strizzi L
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):191-9. PubMed ID: 20369376
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
Radisky ES; Radisky DC
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):201-12. PubMed ID: 20440544
[TBL] [Abstract][Full Text] [Related]
6. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
Godde NJ; Galea RC; Elsum IA; Humbert PO
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):149-68. PubMed ID: 20461450
[TBL] [Abstract][Full Text] [Related]
7. microRNAs and EMT in mammary cells and breast cancer.
Wright JA; Richer JK; Goodall GJ
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):213-23. PubMed ID: 20499142
[TBL] [Abstract][Full Text] [Related]
8. Noncanonical TGF-β signaling during mammary tumorigenesis.
Parvani JG; Taylor MA; Schiemann WP
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
[TBL] [Abstract][Full Text] [Related]
9. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Galliher AJ; Schiemann WP
Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
13. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.
Allington TM; Schiemann WP
Cells Tissues Organs; 2011; 193(1-2):98-113. PubMed ID: 21051857
[TBL] [Abstract][Full Text] [Related]
14. Mammary gland studies as important contributors to the cause of epithelial mesenchymal plasticity in malignancy.
Ford HL; Thompson EW
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):113-5. PubMed ID: 20544376
[No Abstract] [Full Text] [Related]
15. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Wendt MK; Smith JA; Schiemann WP
Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
[TBL] [Abstract][Full Text] [Related]
16. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.
de Herreros AG; Peiró S; Nassour M; Savagner P
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):135-47. PubMed ID: 20455012
[TBL] [Abstract][Full Text] [Related]
17. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.
Junk DJ; Cipriano R; Bryson BL; Gilmore HL; Jackson MW
Neoplasia; 2013 Sep; 15(9):1100-9. PubMed ID: 24027434
[TBL] [Abstract][Full Text] [Related]
19. [The role of TGF-β-related signal transduction pathways in pathogenesis of epithelial-mesenchymal transition as a key element in cancer development and progression].
Pieniążek M; Donizy P; Ziętek M; Szynglarewicz B; Matkowski R
Postepy Hig Med Dosw (Online); 2012 Sep; 66():583-91. PubMed ID: 23001200
[TBL] [Abstract][Full Text] [Related]
20. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.
Neil JR; Johnson KM; Nemenoff RA; Schiemann WP
Carcinogenesis; 2008 Nov; 29(11):2227-35. PubMed ID: 18725385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
